Landmark EVRA Trial Provides First Level 1 Evidence for Early Endovenous Ablation

The first full results of the Early Venous Reflux Ablation (EVRA) ulcer study were presented at the Charing Cross Symposium (CX; 24-27 April, London, UK). The presentation was accompanied by simultaneous publication in the New England Journal of Medicine after the session.

The randomised trial revealed that early endovenous ablation outperforms deferred treatment in healing leg ulcers. It shows early ablation of superficial venous reflux results in faster healing of venous leg ulcers and patients having much more time free from ulcers than deferred ablation does.